Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

First Edition: May 10, 2013

Todya's headlines include reports about efforts by the Obama administration to boost health exchange enrollment.

10 May 2013

FDA approves Novartis' Ilaris for treatment of active systemic juvenile idiopathic arthritis

Novartis announced that the US Food and Drug Administration has approved Ilaris (canakinumab) for the treatment of active systemic juvenile idiopathic arthritis in patients aged 2 years and older.

10 May 2013

GHS patients to have access to doctors' notes through MyGeisinger online patient portal

More than 100,000 Geisinger Health System patients will have access to their doctors' notes for the first time through the secure MyGeisinger online patient portal when Geisinger expands OpenNotes in May due to the initiative's overwhelming success.

9 May 2013

Idera to present data from Phase 2 trial of IMO-3100 in patients with psoriasis at IID 2013

Idera Pharmaceuticals today announced presentation of data from its randomized, double-blind, placebo-controlled Phase 2 trial that showed improvements from baseline of up to 90% in Psoriasis Area Severity Index scores in patients with moderate to severe plaque psoriasis following four weeks of treatment with the Toll-like Receptor antagonist IMO-3100.

8 May 2013

POZEN announces revenue of $1.4 million for first quarter 2013

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, today announced results for the first quarter ended March 31, 2013.

8 May 2013

New treatment could potentially benefit Irish SLE patients, find researchers

Researchers from the Royal College of Surgeons in Ireland have discovered that a new treatment for the inflammatory condition, Systemic Lupus Erythmstosus could potentially benefit Irish patients who suffer from the condition.

8 May 2013

TSRI announces five-year agreement with Janssen to research on influenza virus

The Scripps Research Institute (TSRI) today announced a five-year agreement with Janssen Pharmaceuticals, Inc. (Janssen) to collaborate on focused research projects in the infectious disease area, with the initial project targeting the influenza virus.

7 May 2013

Rigel reports net loss of $25.6 million in first quarter 2013

Rigel Pharmaceuticals, Inc. today reported financial results for the first quarter ended March 31, 2013. For the first quarter of 2013, Rigel reported a net loss of $25.6 million, or $0.29 per share, compared to a net loss of $23.2 million, or $0.32 per share, in the first quarter of 2012. Weighted average shares outstanding for the first quarters of 2013 and 2012 were 87.1 million and 71.4 million, respectively.

7 May 2013

Kinase inhibitors: an interview with Jan Hoflack, CSO of Oncodesign

Kinase inhibitors are molecules that block the activity of kinases. Kinases are a specific class of enzymes. They are extremely important in signal transduction processes in the human body meaning that they actually regulate most of the physiological processes that take place in the body.

7 May 2013

Hospital for Special Surgery signs agreement with Brazilian healthcare organization

Clinical pathways and quality initiatives leading to world class outcomes are the foundation of a far-reaching agreement between New York-based Hospital for Special Surgery, the recognized leader in orthopedics, rheumatology and related specialties, and Amil Par, the largest managed healthcare organization in Brazil, on behalf of Hospitalys Ortopedia, its newly opened orthopedic center in Rio de Janeiro.

7 May 2013

Regeneron Pharmaceuticals expands ophthalmology portfolio

Regeneron Pharmaceuticals, Inc. today announced that it has expanded its ophthalmology portfolio by acquiring full exclusive rights to two families of novel antibodies invented at Regeneron and previously included in Regeneron's antibody collaboration with Sanofi.

3 May 2013

EntreMed announces issuance of patent for clinical-stage compound, 2-methoxyestradiol

EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of a variety of cancers, announced the issuance of a U.S. patent covering methods of treatment and formulations for its clinical-stage compound, 2-methoxyestradiol.

3 May 2013

Regional anesthesia improves outcomes in sleep apnea patients undergoing total joint arthroplasty

Using regional anesthesia instead of general anesthesia in patients with sleep apnea undergoing total joint replacement decreases major complications by 17%, according to a study published online, ahead of print, in the journal Regional Anesthesia and Pain Medicine.

3 May 2013

New study shows that exercise does not worsen pain associated with fibromyalgia

For many people who have fibromyalgia, even the thought of exercising is painful. Yet a new study from Wake Forest Baptist Medical Center shows that exercise does not worsen the pain associated with the disorder and may even lessen it over time.

3 May 2013

Neuraxial anesthesia improves outcomes in patients undergoing hip or knee replacement

A highly underutilized anesthesia technique called neuraxial anesthesia, also known as spinal or epidural anesthesia, improves outcomes in patients undergoing hip or knee replacement, according to a new study by researchers at Hospital for Special Surgery.

2 May 2013

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

First Edition: May 10, 2013

FDA approves Novartis' Ilaris for treatment of active systemic juvenile idiopathic arthritis

GHS patients to have access to doctors' notes through MyGeisinger online patient portal

Idera to present data from Phase 2 trial of IMO-3100 in patients with psoriasis at IID 2013

POZEN announces revenue of $1.4 million for first quarter 2013

New treatment could potentially benefit Irish SLE patients, find researchers

TSRI announces five-year agreement with Janssen to research on influenza virus

Rigel reports net loss of $25.6 million in first quarter 2013

Kinase inhibitors: an interview with Jan Hoflack, CSO of Oncodesign

Hospital for Special Surgery signs agreement with Brazilian healthcare organization

Regeneron Pharmaceuticals expands ophthalmology portfolio

EntreMed announces issuance of patent for clinical-stage compound, 2-methoxyestradiol

Regional anesthesia improves outcomes in sleep apnea patients undergoing total joint arthroplasty

New study shows that exercise does not worsen pain associated with fibromyalgia

Neuraxial anesthesia improves outcomes in patients undergoing hip or knee replacement

TSRI scientists find dissimilar genes that keep very similar shapes

Rituximab joint protective benefits capped

Scientists discover novel drug molecule that reduces swelling, inflammation in arthritic joints

Sufferers of gout and elevated uric acid levels have significantly increased death risks

UCSF study focuses on vexing problems of handling skin cancers among elderly patients

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in